A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

NCT05923424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: REGN17092
DRUG: Matching Placebo

Sponsor

Regeneron Pharmaceuticals